16 September 2022 ORYZON to present preliminary blinded aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borderline Personality Disorder
29 September - 1 October 2022 XIX Congress of the Spanish Society of Psychogeriatrics Valladolid Spain